Detection of BRCA1/2 mutations in circulating tumor DNA from patients with ovarian cancer. Ratajska, M., Koczkowska, M., Żuk, M., Gorczyński, A., Kuźniacka, A., Stukan, M., Biernat, W., Limon, J., & Wasąg, B. Oncotarget, 8(60):101325–101332, September, 2017.
Detection of BRCA1/2 mutations in circulating tumor DNA from patients with ovarian cancer [link]Paper  doi  bibtex   2 downloads  
@article{ratajska_detection_2017,
	title = {Detection of {BRCA1}/2 mutations in circulating tumor {DNA} from patients with ovarian cancer},
	volume = {8},
	issn = {1949-2553},
	url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731877/},
	doi = {10.18632/oncotarget.20722},
	number = {60},
	urldate = {2020-02-11},
	journal = {Oncotarget},
	author = {Ratajska, Magdalena and Koczkowska, Magdalena and Żuk, Monika and Gorczyński, Adam and Kuźniacka, Alina and Stukan, Maciej and Biernat, Wojciech and Limon, Janusz and Wasąg, Bartosz},
	month = sep,
	year = {2017},
	pmid = {29254167},
	pmcid = {PMC5731877},
	keywords = {Alamut, BRCA1, BRCA1/2, BRCA2, Blood, Clinical Trials, Clinical study, Genomics, Hereditary Disorders, Liquid Biopsy, Ovarian Cancer, PARP1 inhibitors, SOPHiA DDM, ctDNA},
	pages = {101325--101332},
}

Downloads: 2